UNIVERSITY OF ALABAMA AT BIRMINGHAM
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1969-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.uab.edu
Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-09-16
- Last Posted Date
- 2015-06-15
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 28
- Registration Number
- NCT00004195
Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2004-08-09
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT00005591
Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-08-09
- Last Posted Date
- 2013-04-12
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 110
- Registration Number
- NCT00005076
Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2013-04-12
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 48
- Registration Number
- NCT00004162
- Locations
- 🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2013-04-12
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 25
- Registration Number
- NCT00004193
- Locations
- 🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2013-04-12
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 55
- Registration Number
- NCT00004186
- Locations
- 🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor
Phase 1
Terminated
- Conditions
- First Posted Date
- 2004-07-26
- Last Posted Date
- 2013-11-20
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 54
- Registration Number
- NCT00004159
- Locations
- 🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2013-11-26
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 72
- Registration Number
- NCT00004160
- Locations
- 🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT00002956
- Locations
- 🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 34
- Registration Number
- NCT00086736
- Locations
- 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
© Copyright 2024. All Rights Reserved by MedPath